SedMed Raises $4M for Non-Electric Toilet Lift

SedMed has announced a $4M financing led by 108 BioCapital to expand commercial distribution for its non-electric toilet lift and fund additional hospital-based studies. The October 1, 2026 investment gives the Milford, Connecticut medical-device company more capital to turn reported hospital adoption into a broader commercial system.

The product addresses an ordinary movement with unusually high stakes: sitting down and standing up from the toilet. For older adults and people with limited mobility, that transfer affects independence and privacy; for family and professional caregivers, it can also create repeated lifting risk. SedMed is betting that a mechanical device, not a more elaborate connected system, can make the handoff safer and easier to deploy.

What SedMed's $4M Financing Covers

108 BioCapital's announcement says the firm is leading a $4M financing in SedMed. The parties did not disclose a conventional round label, other participating investors, the security type, valuation, or SedMed's current total funding, so the transaction is best described simply as a financing rather than a Seed or Series A round.

SedMed plans to use the investment to accelerate commercial expansion, grow distribution and channel partnerships, advance its intellectual-property portfolio, and conduct additional hospital-based studies. Those priorities reveal the company's current operating challenge: SedMed already has a manufactured product and reported institutional adoption, but it still needs distribution breadth and stronger evidence for healthcare buyers.

The announcement says SedMed's lift has been adopted across more than 40 hospital systems. That figure comes from the company and investor, not an independent clinical or procurement audit, and the release does not disclose unit volume, revenue, study outcomes, or customer retention. Even with that boundary, the claim points to a meaningful transition from prototype development to use inside institutions that regularly manage difficult patient transfers.

How SedMed's Non-Electric Toilet Lift Works

The SedMed Toilet Lift mounts to most standard toilets and uses an adjustable gas-spring mechanism instead of a motor, battery, or electrical connection. SedMed says the device has five resistance settings, supports users from 75 to 600 lbs, and can provide up to roughly 80% assistance during sit-to-stand movement.

That design choice matters commercially because it removes several sources of installation and operating friction. A facility or household does not need an outlet, charging routine, or bathroom renovation, and the device can continue operating during a power outage. The product still has to fit the toilet, match the user's mobility and balance needs, and be used according to appropriate clinical or caregiver guidance.

SedMed's origin also explains why the company stayed close to the transfer itself. The company's official history says co-founders Jeremy Bronen and Timothy Krupski developed the idea after Krupski saw his grandmother Grace struggle with bathroom mobility following a stroke. What began as a university design project became a product built around the privacy, dignity, and physical effort inside one daily activity.

The intellectual property has moved beyond a pending concept. U.S. Patent No. 12,150,906, assigned to SedMed and naming Krupski and Bronen as inventors, covers a non-electric toilet seat assist system. The company has also pursued a separate application involving intelligent monitoring, but the product sold today is positioned primarily around simple mechanical assistance.

The Two-Customer Problem in Bathroom Mobility

A toilet transfer can create a two-customer problem. The person using the bathroom wants privacy, control, and enough physical support to complete the movement. The caregiver or clinical worker wants to help without repeatedly absorbing the user's body weight.

OSHA's safe-patient-handling guidance specifically lists toilet-to-chair transfers among high-risk tasks and identifies repeated manual lifting as a contributor to musculoskeletal injuries. OSHA recommends assistive equipment as part of broader safe-patient-handling programs, along with hazard assessment, care planning, training, and worker participation.

SedMed cannot solve every transfer problem, and the company's own guidance says the device is not appropriate for every user. Its narrower value proposition is to reduce how much physical assistance a person or caregiver must supply during a common movement. That makes product fit, user selection, training, and outcome evidence as important as the mechanism itself.

Why Hospital Studies Matter

The additional hospital-based studies may be the most consequential use of the new capital. Distribution can place a device in front of buyers, but healthcare procurement depends on evidence that the device fits workflows, reduces meaningful risk, and produces enough operational value to justify standardization.

SedMed's reported footprint gives the company places to study those questions. The next layer of evidence could help hospitals compare transfer practices, staff burden, patient experience, device utilization, and implementation cost. The October announcement does not specify study designs, endpoints, timelines, or participating health systems, so those details remain open.

For home use, the buying process changes again. The National Institute on Aging describes toileting, mobility, and home safety as central parts of aging in place, often supported by family members and other informal caregivers. A household buyer needs clear fit guidance, confidence that the user can operate the device safely, and a path to support that does not resemble hospital procurement.

A Larger Aging-in-Place Market

The demographic pressure behind SedMed's market is not subtle. U.S. Census Bureau projections show older adults becoming a larger share of the U.S. population through 2060, while many families and health systems already face limited caregiver capacity.

108 BioCapital also sees potential beyond the United States, including India and other international markets. A non-electric design may be easier to deploy where bathroom infrastructure, reliable power, service capacity, or renovation budgets vary, but international opportunity is still a thesis rather than reported revenue. SedMed will need local distribution, regulatory work, pricing, training, and evidence suited to each market.

The $4M financing gives SedMed room to build those commercial and evidence systems around a deliberately simple device. If the company can connect hospital studies, procurement, home adoption, and international distribution, the toilet lift can reduce one of the smallest but most persistent handoffs in care: the moment when a person needs help standing and another person would otherwise have to supply it.